US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

58.79

-0.0300-0.05%

Post-market: 59.000.2100+0.36%19:37 EDT

Volume:1.52M

Turnover:89.14M

Market Cap:7.26B

PE:17.14

High:59.33

Open:58.18

Low:57.51

Close:58.82

Loading ...

Overview Company News Filings

FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting

Halozyme Therapeutics Reports FDA Approval for Self-Injectable Syringe Developed in Partnership With Argenx

MT Newswires Live

Halozyme Says European Commission Approves Darzalex Co-Formulated With Enhanze to Treat Multiple Myeloma

MT Newswires Live

BRIEF-European Commission Approved Subcutaneous Darzalex (Daratumumab) Based Quadruplet Regimen

Johnson & Johnson’s Darzalex with Halozyme’s Enhanze granted EU approval

European Commission Approved Subcutaneous Darzalex® (Daratumumab)-Based Quadruplet Regimen for the Treatment of Patients With Newly Diagnosed Multiple Myeloma, Regardless of Transplant Eligibility

THOMSON REUTERS

European Commission Approved Subcutaneous DARZALEX® (daratumumab)-based Quadruplet Regimen for the Treatment of Patients with Newly Diagnosed Multiple Myeloma, Regardless of Transplant Eligibility

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Johnson & Johnson's Janssen Says Subcutaneous Rybrevant Approved for 2 Indications in EU

MT Newswires Live

BRIEF-European Commission Approves Subcutaneous Rybrevant® (Amivantamab)

European Commission Approves Subcutaneous Rybrevant® (Amivantamab) Co-Formulated With Enhanze® for the Treatment of Patients With Advanced Egfr-Mutated Non-Small Cell Lung Cancer

THOMSON REUTERS

European Commission Approves Subcutaneous RYBREVANT® (amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist?

Simply Wall St.

Why Is Acadia (ACAD) Down 11.1% Since Last Earnings Report?

Top Analyst Reports for Walt Disney, Progressive & Citigroup

BRIEF-Merck Says FDA PDUFA Date For Subcutaneous Pembrolizumab Set For Sept 23

Merck Exec Says Will Launch Subcutaneous Keytruda at Risk IF Halozyme Patent Dispute Not Resolved yet - Interview

THOMSON REUTERS

Myriad (MYGN) Down 17.1% Since Last Earnings Report: Can It Rebound?

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Halozyme Joins the $1 Billion Club

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HALO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HALO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HALO\",,,,,undefined,":{"symbol":"HALO","market":"US","secType":"STK","nameCN":"Halozyme Therapeutics","latestPrice":58.79,"timestamp":1744920000000,"preClose":58.82,"halted":0,"volume":1519339,"hourTrading":{"tag":"盘后","latestPrice":59,"preClose":58.79,"latestTime":"19:37 EDT","volume":63783,"amount":3749907.57,"timestamp":1744933025217},"delay":0,"floatShares":122169996,"shares":123533310,"eps":3.43,"marketStatus":"Closed Good Friday","change":-0.03,"latestTime":"04-17 16:00:00 EDT","open":58.18,"high":59.33,"low":57.51,"amount":89141586.674005,"amplitude":0.030942,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.43,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1099285200000,"exchange":"NASDAQ","adjPreClose":58.82,"preHourTrading":{"tag":"盘前","latestPrice":58.19,"preClose":58.82,"latestTime":"09:29 EDT","volume":1657,"amount":96450.112504,"timestamp":1744896599999},"postHourTrading":{"tag":"盘后","latestPrice":59,"preClose":58.79,"latestTime":"19:37 EDT","volume":63783,"amount":3749907.57,"timestamp":1744933025217},"volumeRatio":0.8997784025575492,"impliedVol":0.3326,"impliedVolPercentile":0.1594},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HALO\",,,,,undefined,":{"symbol":"HALO","floatShares":122169996,"roa":"18.16%","roe":"198.42%","lyrEps":3.501549,"volumeRatio":0.8997784025575492,"shares":123533310,"dividePrice":0,"high":59.33,"amplitude":0.030942,"preClose":58.82,"low":57.51,"week52Low":37.73,"pbRate":"19.96","psRate":"7.15","week52High":66,"institutionHeld":0.9116,"latestPrice":58.79,"eps":3.43,"divideRate":0,"volume":1519339,"delay":0,"ttmEps":3.43,"open":58.18,"prevYearClose":47.81,"prevWeekClose":60.22,"prevMonthClose":63.81,"prevQuarterClose":63.81,"fiveDayClose":57.7,"twentyDayClose":64.32,"sixtyDayClose":55.28},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HALO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526647240","title":"FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting","url":"https://stock-news.laohu8.com/highlight/detail?id=2526647240","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526647240?lang=en_us&edition=fundamental","pubTime":"2025-04-12 05:41","pubTimestamp":1744407712,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration  on Thursday approved a new option for patients to self-inject Argenx SE’s  Vyvgart Hytrulo with a prefilled syringe  for adult patients with generalized myasthenia gravis  who are anti-acetylcholine receptor  antibody positive and adult patients with chronic inflammatory demyelinating polyneuropathy .Vyvgart Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional.The single-dose prefilled subcutaneous injection was developed as part of argenx’s exclusive partnership with Halozyme Therapeutics Inc’s  Enhanze drug delivery technology, enabling rapid, high-volume biologics delivery.Also Read: Argenx’s Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients. The approval of the Vyvgart Hytrulo prefilled syringe for self-injection is supported by data from studies evaluating its bioequivalenceto Vyvgart Hytr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-approves-argenxs-vyvgart-hytrulo-214152717.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4516","HALO","LU2357305700.SGD","BK4581","LU0053671581.USD","LU0225283273.USD","LU0314104364.USD","LU0889565916.HKD","LU1162221912.USD","LU2023251221.USD","LU2347655156.SGD","LU0106261372.USD","LU0795875086.SGD","LU0106831901.USD","LU0267386448.USD","BK4585","LU0320765992.SGD","BK4588","LU1732799900.SGD","LU0912757837.SGD","LU1363072403.SGD","LU1720051108.HKD","LU1548497426.USD","LU2089284900.SGD","ARGX","BK4139","LU2133065610.SGD","LU1989772840.SGD","BK4534","LU0158827781.USD","LU1720051017.SGD","HOME","LU1989772923.USD","LU1668664300.SGD","BK4504","LU1732800096.USD","ARGNF","LU0320765646.SGD","LU0098860793.USD","BK4127","LU0109394709.USD","LU0158827948.USD","LU2028103732.USD","LU1074936037.SGD","LU0795875169.SGD","LU0971096721.USD","LU2089283258.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4505","LU2111349929.HKD"],"gpt_icon":0},{"id":"2526364026","title":"Halozyme Therapeutics Reports FDA Approval for Self-Injectable Syringe Developed in Partnership With Argenx","url":"https://stock-news.laohu8.com/highlight/detail?id=2526364026","media":"MT Newswires Live","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526364026?lang=en_us&edition=fundamental","pubTime":"2025-04-11 16:36","pubTimestamp":1744360612,"startTime":"0","endTime":"0","summary":"Halozyme Therapeutics  said late Thursday that argenx  received the US Food and Drug Administration's approval for Vyvgart hytrulo prefilled syringe for self-injection to treat adult patients with generalized myasthenia gravis.The company said the treatment is for anti-acetylcholine receptor antibody-positive patients and adult patients with chronic inflammatory demyelinating polyneuropathy.The single-dose prefilled subcutaneous injection was developed in Argenx's exclusive partnership with Halozyme.\"We are delighted that Argenx continues to expand use of Halozyme's proven ENHANZE technology to support patient independence and convenience,\" said Helen Torley, chief executive officer of Halozyme.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","BK4585","HALO","BK4139","ARGX","BK4505","LU0053671581.USD","LU0109394709.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2526364772","title":"Halozyme Says European Commission Approves Darzalex Co-Formulated With Enhanze to Treat Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2526364772","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526364772?lang=en_us&edition=fundamental","pubTime":"2025-04-09 21:34","pubTimestamp":1744205688,"startTime":"0","endTime":"0","summary":"Halozyme Therapeutics  said Wednesday that Johnson & Johnson  unit Janssen-Cilag International received European Commission approval for an indication extension of Darzalex co-formulated with Halozyme's Enhanze drug delivery technology to treat adults newly diagnosed with multiple myeloma.The latest approval covers people with the disease regardless of transplant eligibility, Halozyme said.Halozyme's Enhanze drug delivery technology is used for the subcutaneous delivery of injected drugs, the company said.Halozyme shares were 1% lower in early trading on Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0034235303.USD","SG9999002232.USD","HALO","BK4592","BK4534","LU1221951046.USD","LU1280957306.USD","LU1267930813.SGD","LU1057294990.SGD","LU0345769631.USD","LU2602419157.SGD","LU1935042991.SGD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","LU0289739699.SGD","LU2129689514.USD","IE0002270589.USD","LU0058720904.USD","LU0234570918.USD","LU1196500208.SGD","IE00BSNM7G36.USD","LU1059921491.USD","IE00B3PB1722.GBP","BK4532","LU1914381329.SGD","LU0203345920.USD","LU2430703095.HKD","SG9999002224.SGD","BK4139","LU0345769128.USD","IE00B7SZLL34.SGD","LU1061106388.HKD","LU1162221912.USD","LU0466842654.USD","BK4007","LU2592432038.USD","LU0098860793.USD","LU1066053197.SGD","SG9999001440.SGD","LU1261432733.SGD","BK4588","LU2468319806.SGD","LU0985320562.USD","LU1674673428.USD","JNJ","LU1074936037.SGD","LU2430703251.USD","LU1506573853.SGD","LU1244550494.USD","LU1894683348.USD"],"gpt_icon":0},{"id":"2526361611","title":"BRIEF-European Commission Approved Subcutaneous Darzalex (Daratumumab) Based Quadruplet Regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2526361611","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526361611?lang=en_us&edition=fundamental","pubTime":"2025-04-09 21:10","pubTimestamp":1744204255,"startTime":"0","endTime":"0","summary":"BRIEF-European Commission Approved Subcutaneous Darzalex (Daratumumab) Based Quadruplet RegimenApril 9 (Reuters) - Halozyme Therapeutics Inc HALO.O:EUROPEAN COMMISSION APPROVED SUBCUTANEOUS DARZALEX (","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nTUA3PPPHB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HALO","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2526694533","title":"Johnson & Johnson’s Darzalex with Halozyme’s Enhanze granted EU approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2526694533","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526694533?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:56","pubTimestamp":1744203403,"startTime":"0","endTime":"0","summary":"Halozyme (HALO) announced that Janssen-Cilag International, a Johnson & Johnson (JNJ) company, received European Commission approval for an indicat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnsons-darzalex-with-halozymes-enhanze-granted-eu-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnsons-darzalex-with-halozymes-enhanze-granted-eu-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765646.SGD","BK4550","LU1196500208.SGD","LU0203345920.USD","LU0912757837.SGD","JNJ","BK4568","IE00BVYPNW00.USD","IE00BJT1NW94.SGD","LU2430703095.HKD","LU2347655156.SGD","BK4559","LU1032466523.USD","LU1032955483.USD","LU0345770308.USD","LU1057294990.SGD","LU1066053197.SGD","LU2430703178.SGD","IE00B7SZLL34.SGD","BK4156","IE00B3T34201.USD","LU0889566641.SGD","LU1059921491.USD","IE00B2B36J28.USD","LU0234570918.USD","SG9999001440.SGD","LU1674673428.USD","HALO","IE0002141913.USD","LU1244550577.SGD","LU1894683348.USD","IE00BGHQF631.EUR","LU2112291526.USD","BK4592","LU2129689514.USD","LU0795875086.SGD","LU1244550221.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","BK4139","IE00B4R5TH58.HKD","LU0345769128.USD","LU0122379950.USD","LU1023059063.AUD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1778281490.HKD","LU1261432733.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"2526736641","title":"European Commission Approved Subcutaneous Darzalex® (Daratumumab)-Based Quadruplet Regimen for the Treatment of Patients With Newly Diagnosed Multiple Myeloma, Regardless of Transplant Eligibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2526736641","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526736641?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:45","pubTimestamp":1744202702,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nTUA3PPPHB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HALO","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2526364356","title":"European Commission Approved Subcutaneous DARZALEX® (daratumumab)-based Quadruplet Regimen for the Treatment of Patients with Newly Diagnosed Multiple Myeloma, Regardless of Transplant Eligibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2526364356","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526364356?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:45","pubTimestamp":1744202700,"startTime":"0","endTime":"0","summary":"Subcutaneous DARZALEX is co-formulated with Halozyme's ENHANZE drug delivery technology. \"The continued expansion of DARZALEX delivered subcutaneously with ENHANZE into additional settings highlights its status as a cornerstone of therapy for multiple myeloma,\" said Dr. Helen Torley, President and CEO of Halozyme. \"This approval means that newly diagnosed patients can receive daratumumab subcutaneous plus VRd and avoid the need for lengthy IV infusions.\". Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. As the innovators of ENHANZEdrug delivery technology with the proprietary enzyme rHuPH20, Halozyme's commercially-validated solution is used to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. Having touched one million patient lives in post-marketing us","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/european-commission-approved-subcutaneous-darzalex-124500291.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-commission-approved-subcutaneous-darzalex-124500291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TE","EC","BK4139","BK4096","HALO","BK4201","LU0053671581.USD"],"gpt_icon":0},{"id":"2525581244","title":"Why This 1 Value Stock Could Be a Great Addition to Your Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2525581244","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525581244?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:40","pubTimestamp":1744119609,"startTime":"0","endTime":"0","summary":"For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.Why Investors Should Pay Attention to This Value Stock. Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, the Value Style Score identifies the most attractive and most discounted stocks.Many value investors pay close attention to a company's earnings as well. For HALO, two analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.07 to $5.01 per share for 2025. Per share HALO boasts an average earnings surprise of 17%.This article originally publis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-1-value-stock-could-134009792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0053671581.USD","HALO","BK4139"],"gpt_icon":0},{"id":"2525853042","title":"Johnson & Johnson's Janssen Says Subcutaneous Rybrevant Approved for 2 Indications in EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2525853042","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525853042?lang=en_us&edition=fundamental","pubTime":"2025-04-07 22:18","pubTimestamp":1744035516,"startTime":"0","endTime":"0","summary":"Johnson & Johnson's (JNJ) Janssen-Cilag International said Monday it received European Commission approval for its subcutaneous formulation of Rybrevant, or amivantamab, in two indications.The subcuta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1674673691.USD","LU0320765646.SGD","LU1196500208.SGD","LU1162221912.USD","LU0114720955.EUR","IE00B1BXHZ80.USD","JNJ","LU0912757837.SGD","BK4568","IE00BVYPNW00.USD","LU2347655156.SGD","LU2592432038.USD","LU1074936037.SGD","LU2505996681.GBP","BK4559","IE00B19Z3581.USD","BK4532","IE00B42XCP33.USD","BK4156","IE000M9KFDE8.USD","LU1059921491.USD","LU2129689605.HKD","LU1674673428.USD","LU1894683264.USD","LU2430703251.USD","SG9999002232.USD","BK4585","HALO","LU1244550577.SGD","LU1506573853.SGD","LU1894683348.USD","IE00BGHQF631.EUR","IE00BSNM7G36.USD","LU1914381329.SGD","LU0289739699.SGD","BK4534","BK4592","BK4533","LU0345769631.USD","LU2129689431.USD","LU1244550494.USD","BK4588","LU0640476718.USD","LU0345769128.USD","LU0792757196.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1778281490.HKD","LU1935042991.SGD"],"gpt_icon":1},{"id":"2525045078","title":"BRIEF-European Commission Approves Subcutaneous Rybrevant® (Amivantamab)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525045078","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525045078?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:30","pubTimestamp":1744032651,"startTime":"0","endTime":"0","summary":"BRIEF-European Commission Approves Subcutaneous Rybrevant (Amivantamab)April 7 (Reuters) - Halozyme Therapeutics Inc HALO.O:EUROPEAN COMMISSION APPROVES SUBCUTANEOUS RYBREVANT (AMIVANTAMAB) CO-FORMULA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL0YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","HALO","BK4139"],"gpt_icon":0},{"id":"2525423045","title":"European Commission Approves Subcutaneous Rybrevant® (Amivantamab) Co-Formulated With Enhanze® for the Treatment of Patients With Advanced Egfr-Mutated Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525423045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525423045?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:29","pubTimestamp":1744032560,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL0YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HALO","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2525466100","title":"European Commission Approves Subcutaneous RYBREVANT® (amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525466100","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525466100?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:25","pubTimestamp":1744032300,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April 7, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc.   today announced that Janssen-Cilag International NV, a Johnson & Johnson company, has received European Commission  marketing authorization ofthe subcutaneous  formulation of RYBREVANT , in combination withLAZCLUZE , for the first-line treatment of adult patients with advanced non-small cell lung cancer  with epidermal growth factor receptor  exon19 deletions or exon 21 L858R substitution mutations. Additionally, it is approved as amonotherapy for adult patients with advanced NSCLC with activating EGFR exon 20 insertion mutations after the failure of platinum-based therapy.Subcutaneous amivantamab is co-formulated Halozyme's ENHANZE drug delivery technology.Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide commercial or functional advantages such as improved convenience, rel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/european-commission-approves-subcutaneous-rybrevant-132500621.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-commission-approves-subcutaneous-rybrevant-132500621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HALO","LU0053671581.USD","BK4139","IE00B66KJ199.SGD","IE00B7SZL793.SGD","AEIS","EC","IE00B19Z4B17.USD","BK4157","BK4201","IE0031619046.USD"],"gpt_icon":0},{"id":"2523646431","title":"Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523646431","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523646431?lang=en_us&edition=fundamental","pubTime":"2025-03-29 22:58","pubTimestamp":1743260323,"startTime":"0","endTime":"0","summary":"The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-halo/halozyme-therapeutics/news/is-now-the-time-to-put-halozyme-therapeutics-nasdaqhalo-on-y-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2095319765.USD","LU2210149790.SGD","MNQmain","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NQmain","BK4139","LU0053671581.USD","SQQQ","NVIW.SI","BK4112","QID","LU2210150020.SGD","EBIT","USJW.SI","BK4588","TSYW.SI","IE00BKPKM429.USD","USAW.SI","QLD","NDAQ","IE00B64PRP62.GBP","PSQ","TQQQ","HALO",".IXIC","BK4585"],"gpt_icon":1},{"id":"2523685661","title":"Why Is Acadia (ACAD) Down 11.1% Since Last Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523685661","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523685661?lang=en_us&edition=fundamental","pubTime":"2025-03-28 23:30","pubTimestamp":1743175840,"startTime":"0","endTime":"0","summary":"A month has gone by since the last earnings report for Acadia Pharmaceuticals . Shares have lost about 11.1% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Acadia due for a breakout?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.It turns out, fresh estimates have trended downward during the past month.The consensus estimate has shifted -62.99% due to these changes.Acadia belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Halozyme Therapeutics , has gained 11.8% over the past month. More than a month has passed since the company reported results for the quarter ended December 2024.Halozyme Therapeutics, Inc.  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-acadia-acad-down-11-153040839.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HALO","ACAD"],"gpt_icon":0},{"id":"2522582215","title":"Top Analyst Reports for Walt Disney, Progressive & Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2522582215","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522582215?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:16","pubTimestamp":1743106560,"startTime":"0","endTime":"0","summary":"Thursday, March 27, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Walt Disn","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-analyst-reports-walt-disney-201600996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4598","CCL","IE0004445015.USD","LU0130102774.USD","LU0742537680.HKD","LU0130517989.USD","PGR","BK4602","BK4559","LU1481011911.USD","LU1941712264.USD","DIS","BK4561","SWX","BK4170","IE00BN29S564.USD","LU2125154778.USD","LU1169589451.USD","HALO","IE00BZ1G4Q59.USD","C","LU2404859741.USD","LU1069347547.HKD","HOG","MGM","CNQ","BK4548","BK4214","LU1481011671.HKD","LU1983260115.SGD","RHI","BK4116","CACC","LU0980610538.SGD","TISI","LU1235295455.SGD","LU1291159041.SGD","FORM","BK4507","TCX","LU1989771016.USD","LU0052756011.USD","GIII","CVNA","LU0708994859.HKD","GB00B4LPDJ14.GBP","STX","LU0742534661.SGD","LU1035773651.USD","IDXX"],"gpt_icon":1},{"id":"2522588145","title":"BRIEF-Merck Says FDA PDUFA Date For Subcutaneous Pembrolizumab Set For Sept 23","url":"https://stock-news.laohu8.com/highlight/detail?id=2522588145","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522588145?lang=en_us&edition=fundamental","pubTime":"2025-03-27 23:00","pubTimestamp":1743087603,"startTime":"0","endTime":"0","summary":"BRIEF-Merck Says FDA PDUFA Date For Subcutaneous Pembrolizumab Set For Sept 23March 27  - Merck & Co Inc MRK.N:MERCK: INVESTIGATIONAL SUBCUTANEOUS PEMBROLIZUMAB WITH BERAHYALURONIDASE ALFA SHOWS NONINFERIOR PHARMACOKINETICS VERSUS IV KEYTRUDA IN 3475A-D77 TRIALMERCK: APPLICATIONS FOR SUBCUTANEOUS PEMBROLIZUMAB ARE UNDER REVIEW IN U.S. & EUROPEMERCK: FDA HAS SET PDUFA DATE OF SEPT 23MERCK EXEC SAYS WILL LAUNCH SUBCUTANEOUS KEYTRUDA AT RISK IF HALOZYME PATENT DISPUTE NOT RESOLVED YET - INTERVIEWMERCK EXEC SAYS HOPES TO LAUNCH SUBCUTANEOUS KEYTRUDA ON OCT 1, SEES PEAK ADOPTION ABOUT 18-24 MONTHS AFTER APPROVAL - INTERVIEWFurther company coverage: MRK.N ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nP8N3JT0JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU0985320562.USD","LU0106261372.USD","LU1162221912.USD","LU1571399168.USD","LU1585245621.USD","SG9999015341.SGD","LU0265550946.USD","LU1061106388.HKD","LU1116320901.HKD","SG9999014542.SGD","LU0965509283.SGD","LU1989771016.USD","BK4559","BK4588","LU0122379950.USD","LU1093756325.SGD","LU1035773651.USD","LU0965509101.SGD","LU1093756168.USD","BK4534","MRK","LU0211331839.USD","LU1037948897.HKD","LU0006306889.USD","LU1929549753.HKD","HALO","SG9999015358.SGD","LU1291159041.SGD","LU1989772923.USD","IE0002141913.USD","BK4533","LU0861579265.USD","IE000M9KFDE8.USD","LU0320765489.SGD","LU0265550359.USD","BK4516","LU1941712264.USD","LU1037948541.HKD","LU1974910355.USD","LU2089984988.USD","LU0058720904.USD","SG9999013999.USD","SG9999014559.SGD","IE00BN8TJ469.HKD","LU2361045086.USD","IE0009355771.USD","LU1066051811.HKD","LU2361044865.SGD","LU2106854487.HKD"],"gpt_icon":0},{"id":"2522007743","title":"Merck Exec Says Will Launch Subcutaneous Keytruda at Risk IF Halozyme Patent Dispute Not Resolved yet - Interview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522007743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522007743?lang=en_us&edition=fundamental","pubTime":"2025-03-27 23:00","pubTimestamp":1743087600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nP8N3JT0JW:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1934455194.USD","LU0208291251.USD","LU1941712264.USD","HALO","LU1066053197.SGD","IE000M9KFDE8.USD","LU0320765489.SGD","LU1974910355.USD","LU1917777945.USD","LU1057294990.SGD","LU2468319806.SGD","BK4585","BK4139","LU1037948541.HKD","SG9999001176.SGD","MRK","LU0320765646.SGD","BK4588","LU0289739699.SGD","LU0965508806.USD","LU2361045086.USD","LU0265550946.USD","LU1093756168.USD","SG9999001176.USD","LU2089984988.USD","LU0203345920.USD","LU1929549753.HKD","LU1035773651.USD","IE00BBT3K403.USD","BK4559","LU1093756325.SGD","LU1291159041.SGD","LU0203347892.USD","LU0265550359.USD","SG9999014559.SGD","LU2106854487.HKD","LU2112291526.USD","LU0211331839.USD","LU1066051498.USD","SG9999002224.SGD","LU1934455863.HKD","LU0965509101.SGD","LU0965509283.SGD","LU2461242641.AUD","LU0070302665.USD","SG9999013999.USD","LU1061106388.HKD","LU1069347547.HKD","LU1989772840.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2522367263","title":"Myriad (MYGN) Down 17.1% Since Last Earnings Report: Can It Rebound?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522367263","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522367263?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:30","pubTimestamp":1743003017,"startTime":"0","endTime":"0","summary":"A month has gone by since the last earnings report for Myriad Genetics . Shares have lost about 17.1% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Myriad due for a breakout?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.It turns out, estimates review have trended downward during the past month.The consensus estimate has shifted -73.61% due to these changes.Myriad is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Halozyme Therapeutics , a stock from the same industry, has gained 11.8%. The company reported its results for the quarter ended December 2024 more than a month ago.Halozyme Therapeutics, Inc.  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/myriad-mygn-down-17-1-153017832.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MYGN","HALO"],"gpt_icon":0},{"id":"2522377446","title":"Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick","url":"https://stock-news.laohu8.com/highlight/detail?id=2522377446","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522377446?lang=en_us&edition=fundamental","pubTime":"2025-03-24 21:50","pubTimestamp":1742824207,"startTime":"0","endTime":"0","summary":"For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.Is This 1 Momentum Stock a Screaming Buy Right Now?Momentum investors, who live by the saying \"the trend is your friend,\" are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.Momentum investors also pay close attention to a company's earnings. For HALO, three analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.11 to $5.02 per share for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/momentum-investor-1-stock-could-135007907.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0053671581.USD","HALO","BK4139"],"gpt_icon":0},{"id":"2521326182","title":"Halozyme Joins the $1 Billion Club","url":"https://stock-news.laohu8.com/highlight/detail?id=2521326182","media":"FX Empire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521326182?lang=en_us&edition=fundamental","pubTime":"2025-03-21 19:35","pubTimestamp":1742556925,"startTime":"0","endTime":"0","summary":"HALO develops novel oncology treatments targeting tumors and offers a health care technology platform that provides subcutaneous drug delivery. Its drug-device combination products are designed to provide improved convenience and tolerability, as well as more patient comfort. The company’s product pipeline and regulatory situation make it primed for growth.Halozyme’s fourth-quarter fiscal 2024 earnings report showed that it passed $1 billion in annual revenue for the first time ever, representing 22% growth. Royalty revenue jumped 27%, to $571 million, while net income increased 58%, to $444 million. Non-GAAP per-share earnings rose 53% in 2024, to $4.23. Plus, the company expects 2025 EPS of up to $5.35.It’s no surprise HALO shares are up 34% this year – and they could rise more. MAPsignals data shows how Big Money investors are betting heavily on the forward picture of the stock.Institutional volumes reveal plenty. Recently, HALO has enjoyed strong investor demand, which we believe t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/halozyme-joins-1-billion-club-113525165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HALO","LU0053671581.USD","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HALO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-18","symbol":"HALO","fiscalQuarterEnding":"2024/12","expectedEps":1.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739854800000,"reportTimeType":"post","actualEps":1.19},{"market":"US","date":"2024-10-31","symbol":"HALO","fiscalQuarterEnding":"2024/09","expectedEps":0.93,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"post","actualEps":1.17},{"market":"US","date":"2024-08-06","symbol":"HALO","fiscalQuarterEnding":"2024/06","expectedEps":0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":0.85},{"market":"US","date":"2024-05-07","symbol":"HALO","fiscalQuarterEnding":"2024/03","expectedEps":0.64,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"post","actualEps":0.71},{"market":"US","date":"2024-02-20","symbol":"HALO","fiscalQuarterEnding":"2023/12","expectedEps":0.77,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1708405200000,"reportTimeType":"post","actualEps":0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HALO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HALO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1739505600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HALO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HALO","date":"2025-04-17","current":16.362028,"percent":0.348371,"low":-107.183322,"twenty":13.693319,"median":18.781965,"eighty":33.483467,"high":317.300641,"avg":28.293626,"sd":70.728226,"marketCap":7266229294},"quantilePoints":[{"date":"2020-04-24","current":-44.69326,"twenty":-44.12368,"median":-29.973062,"eighty":-3.15906,"marketCap":3228641081},{"date":"2020-05-01","current":-44.216175,"twenty":-44.294008,"median":-30.042817,"eighty":-3.15906,"marketCap":3194176509},{"date":"2020-05-08","current":-45.055844,"twenty":-44.594759,"median":-30.187404,"eighty":-3.15906,"marketCap":3254834156},{"date":"2020-05-15","current":-41.033611,"twenty":-44.594759,"median":-30.298421,"eighty":-3.15906,"marketCap":3288392562},{"date":"2020-05-22","current":-41.625849,"twenty":-44.594759,"median":-30.49048,"eighty":-3.15906,"marketCap":3335853898},{"date":"2020-05-29","current":-41.067453,"twenty":-44.594759,"median":-30.668709,"eighty":-3.15906,"marketCap":3291104638},{"date":"2020-06-05","current":-39.933741,"twenty":-44.594759,"median":-30.812227,"eighty":-3.15906,"marketCap":3200250081},{"date":"2020-06-12","current":-38.613897,"twenty":-44.594759,"median":-30.979158,"eighty":-3.15906,"marketCap":3094479103},{"date":"2020-06-19","current":-41.355112,"twenty":-44.594759,"median":-31.0693,"eighty":-3.15906,"marketCap":3314157287},{"date":"2020-06-26","current":-41.930428,"twenty":-44.594759,"median":-31.139245,"eighty":-3.15906,"marketCap":3360262585},{"date":"2020-07-02","current":-48.24199,"twenty":-44.701441,"median":-31.202245,"eighty":-3.15906,"marketCap":3866064822},{"date":"2020-07-10","current":-47.209804,"twenty":-45.062427,"median":-31.437868,"eighty":-3.15906,"marketCap":3783346494},{"date":"2020-07-17","current":-48.411201,"twenty":-45.521478,"median":-31.437868,"eighty":-3.15906,"marketCap":3879625204},{"date":"2020-07-24","current":-45.974566,"twenty":-45.983455,"median":-31.437868,"eighty":-3.15906,"marketCap":3684355707},{"date":"2020-07-31","current":-46.008408,"twenty":-46.067124,"median":-31.437868,"eighty":-3.15906,"marketCap":3687067784},{"date":"2020-08-07","current":-49.020359,"twenty":-46.36488,"median":-31.441816,"eighty":-3.15906,"marketCap":3928442578},{"date":"2020-08-14","current":-96.120349,"twenty":-46.767175,"median":-31.593823,"eighty":-3.15906,"marketCap":3815785605},{"date":"2020-08-21","current":-97.016415,"twenty":-47.040571,"median":-31.929194,"eighty":-3.15906,"marketCap":3851357648},{"date":"2020-08-28","current":-98.015874,"twenty":-47.270147,"median":-32.18744,"eighty":-3.15906,"marketCap":3891034156},{"date":"2020-09-04","current":-95.465531,"twenty":-47.383873,"median":-32.575504,"eighty":-3.15906,"marketCap":3789790651},{"date":"2020-09-11","current":-93.225365,"twenty":-47.596823,"median":-32.914129,"eighty":-3.15906,"marketCap":3700860546},{"date":"2020-09-18","current":-95.603387,"twenty":-47.790417,"median":-33.18736,"eighty":-3.15906,"marketCap":3795263273},{"date":"2020-09-25","current":-89.81342,"twenty":-47.978021,"median":-33.526721,"eighty":-3.15906,"marketCap":3565413154},{"date":"2020-10-02","current":-88.951818,"twenty":-48.050649,"median":-33.7556,"eighty":-3.15906,"marketCap":3531209268},{"date":"2020-10-09","current":-98.394979,"twenty":-48.187806,"median":-34.043096,"eighty":-3.15906,"marketCap":3906083866},{"date":"2020-10-16","current":-99.101493,"twenty":-48.346973,"median":-34.184192,"eighty":-3.15906,"marketCap":3934131053},{"date":"2020-10-23","current":-107.183322,"twenty":-48.421961,"median":-34.367641,"eighty":-3.15906,"marketCap":4254963511},{"date":"2020-10-30","current":-96.499454,"twenty":-48.601018,"median":-34.551796,"eighty":-3.15906,"marketCap":3830835316},{"date":"2020-11-06","current":236.345082,"twenty":-48.601018,"median":-34.551796,"eighty":29.277338,"marketCap":5087091551},{"date":"2020-11-13","current":243.619168,"twenty":-48.601018,"median":-34.551796,"eighty":30.270811,"marketCap":5243658975},{"date":"2020-11-20","current":247.381626,"twenty":-48.601018,"median":-34.551796,"eighty":31.990572,"marketCap":5324642125},{"date":"2020-11-27","current":252.272822,"twenty":-48.601018,"median":-34.551796,"eighty":32.174967,"marketCap":5429920220},{"date":"2020-12-04","current":251.583038,"twenty":-48.601018,"median":-34.551796,"eighty":32.336782,"marketCap":5415073310},{"date":"2020-12-11","current":257.414848,"twenty":-48.601018,"median":-34.551796,"eighty":32.479782,"marketCap":5540597192},{"date":"2020-12-18","current":269.078469,"twenty":-48.601018,"median":-34.551796,"eighty":32.679229,"marketCap":5791644958},{"date":"2020-12-24","current":269.078469,"twenty":-48.601018,"median":-34.551796,"eighty":33.01772,"marketCap":5791644958},{"date":"2020-12-31","current":267.824316,"twenty":-48.601018,"median":-34.551796,"eighty":33.405518,"marketCap":5764650575},{"date":"2021-01-08","current":273.217173,"twenty":-48.601018,"median":-34.551796,"eighty":33.751729,"marketCap":5880726423},{"date":"2021-01-15","current":297.42232,"twenty":-48.601018,"median":-34.551796,"eighty":34.154386,"marketCap":6401718023},{"date":"2021-01-22","current":310.402801,"twenty":-48.601018,"median":-34.551796,"eighty":34.361359,"marketCap":6681109891},{"date":"2021-01-29","current":298.425643,"twenty":-48.601018,"median":-34.551796,"eighty":34.549517,"marketCap":6423313530},{"date":"2021-02-05","current":306.765758,"twenty":-48.601018,"median":-34.551796,"eighty":35.341963,"marketCap":6602826179},{"date":"2021-02-12","current":312.534861,"twenty":-48.601018,"median":-34.551796,"eighty":35.835964,"marketCap":6727000343},{"date":"2021-02-19","current":311.531539,"twenty":-48.601018,"median":-34.551796,"eighty":36.003422,"marketCap":6705404836},{"date":"2021-02-26","current":47.398688,"twenty":-48.601018,"median":-34.551796,"eighty":36.116456,"marketCap":6118459609},{"date":"2021-03-05","current":45.730264,"twenty":-48.601018,"median":-34.551796,"eighty":36.694185,"marketCap":5903091145},{"date":"2021-03-12","current":49.597942,"twenty":-48.601018,"median":-34.551796,"eighty":37.66544,"marketCap":6402350381},{"date":"2021-03-19","current":49.329664,"twenty":-48.601018,"median":-34.551796,"eighty":38.054779,"marketCap":6367719683},{"date":"2021-03-26","current":46.289177,"twenty":-48.601018,"median":-34.551796,"eighty":38.314339,"marketCap":5975238433},{"date":"2021-04-01","current":47.42936,"twenty":-48.601018,"median":-34.551796,"eighty":38.913,"marketCap":6122418902},{"date":"2021-04-09","current":47.809421,"twenty":-48.601018,"median":-34.551796,"eighty":39.059526,"marketCap":6171479058},{"date":"2021-04-16","current":51.878307,"twenty":-48.601018,"median":-34.551796,"eighty":39.557713,"marketCap":6696711318},{"date":"2021-04-23","current":56.405503,"twenty":-48.601018,"median":-34.551796,"eighty":39.888442,"marketCap":7281104355},{"date":"2021-04-30","current":55.835412,"twenty":-48.601018,"median":-34.551796,"eighty":41.446657,"marketCap":7207514121},{"date":"2021-05-07","current":53.174986,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":6864093027},{"date":"2021-05-14","current":37.552701,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":6124207184},{"date":"2021-05-21","current":36.837079,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":6007501400},{"date":"2021-05-28","current":36.138911,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":5893642099},{"date":"2021-06-04","current":34.445855,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":5617533292},{"date":"2021-06-11","current":37.343251,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":6090049394},{"date":"2021-06-18","current":36.138911,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":5893642099},{"date":"2021-06-25","current":39.394119,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":6424511092},{"date":"2021-07-02","current":40.511187,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":6606685975},{"date":"2021-07-09","current":39.708294,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":6475747778},{"date":"2021-07-16","current":36.697446,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":5984729540},{"date":"2021-07-23","current":37.430522,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":6104281807},{"date":"2021-07-30","current":36.069095,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":5882256168},{"date":"2021-08-06","current":35.344746,"twenty":-48.601018,"median":-34.551796,"eighty":42.278935,"marketCap":5764127143},{"date":"2021-08-13","current":25.795567,"twenty":-48.601018,"median":-34.504292,"eighty":42.278935,"marketCap":5900065332},{"date":"2021-08-20","current":24.60127,"twenty":-48.601018,"median":-34.388238,"eighty":42.278935,"marketCap":5626900986},{"date":"2021-08-27","current":26.131463,"twenty":-48.601018,"median":-34.367641,"eighty":42.278935,"marketCap":5976892804},{"date":"2021-09-03","current":26.262089,"twenty":-48.601018,"median":-34.367641,"eighty":42.278935,"marketCap":6006770155},{"date":"2021-09-10","current":25.6525,"twenty":-48.601018,"median":-34.178321,"eighty":42.278935,"marketCap":5867342520},{"date":"2021-09-17","current":26.150124,"twenty":-48.601018,"median":-33.758487,"eighty":42.278935,"marketCap":5981160997},{"date":"2021-09-24","current":25.061572,"twenty":-48.601018,"median":-33.171948,"eighty":42.278935,"marketCap":5732183078},{"date":"2021-10-01","current":25.347706,"twenty":-48.601018,"median":-32.890356,"eighty":42.278935,"marketCap":5797628702},{"date":"2021-10-08","current":23.301229,"twenty":-48.601018,"median":-32.346317,"eighty":42.278935,"marketCap":5329550213},{"date":"2021-10-15","current":23.487837,"twenty":-48.601018,"median":-32.098233,"eighty":42.278935,"marketCap":5372232142},{"date":"2021-10-22","current":24.17829,"twenty":-48.601018,"median":-31.697483,"eighty":42.278935,"marketCap":5530155280},{"date":"2021-10-29","current":23.680667,"twenty":-48.601018,"median":-31.697483,"eighty":42.278935,"marketCap":5416336802},{"date":"2021-11-05","current":14.003587,"twenty":-48.601018,"median":-31.697483,"eighty":42.278935,"marketCap":5728923584},{"date":"2021-11-12","current":13.401615,"twenty":-48.601018,"median":-31.535195,"eighty":42.278935,"marketCap":5482654454},{"date":"2021-11-19","current":12.22175,"twenty":-48.601018,"median":-31.427822,"eighty":42.278935,"marketCap":4999966960},{"date":"2021-11-26","current":11.643857,"twenty":-48.601018,"median":-31.080309,"eighty":42.278935,"marketCap":4763548595},{"date":"2021-12-03","current":11.145081,"twenty":-48.601018,"median":-31.004277,"eighty":42.278935,"marketCap":4559497030},{"date":"2021-12-10","current":11.867447,"twenty":-48.601018,"median":-30.736638,"eighty":42.278935,"marketCap":4855019986},{"date":"2021-12-17","current":13.253702,"twenty":-48.601018,"median":-30.490499,"eighty":42.278935,"marketCap":5422142611},{"date":"2021-12-23","current":13.841915,"twenty":-48.601018,"median":-30.266744,"eighty":42.278935,"marketCap":5662782732},{"date":"2021-12-31","current":13.831595,"twenty":-48.601018,"median":-30.140046,"eighty":42.278935,"marketCap":5658560975},{"date":"2022-01-07","current":12.827162,"twenty":-48.601018,"median":-29.9433,"eighty":42.251694,"marketCap":5247643341},{"date":"2022-01-14","current":12.23207,"twenty":-48.601018,"median":-29.809866,"eighty":42.251694,"marketCap":5004188716},{"date":"2022-01-21","current":11.657617,"twenty":-48.601018,"median":-29.710372,"eighty":42.251694,"marketCap":4769177604},{"date":"2022-01-28","current":11.200118,"twenty":-48.601018,"median":-29.528999,"eighty":42.251694,"marketCap":4582013065},{"date":"2022-02-04","current":11.59226,"twenty":-48.601018,"median":-29.249403,"eighty":42.251694,"marketCap":4742439812},{"date":"2022-02-11","current":11.764252,"twenty":-48.601018,"median":-29.15233,"eighty":42.251694,"marketCap":4812802421},{"date":"2022-02-18","current":11.255155,"twenty":-48.601018,"median":-28.987825,"eighty":42.251694,"marketCap":4604529100},{"date":"2022-02-25","current":12.149203,"twenty":-48.601018,"median":-28.765504,"eighty":42.251694,"marketCap":4892605710},{"date":"2022-03-04","current":12.005588,"twenty":-48.601018,"median":-28.600635,"eighty":42.251694,"marketCap":4834770236},{"date":"2022-03-11","current":11.87223,"twenty":-48.601018,"median":-28.483216,"eighty":42.251694,"marketCap":4781065867},{"date":"2022-03-18","current":12.75786,"twenty":-48.601018,"median":-28.095678,"eighty":42.251694,"marketCap":5137717958},{"date":"2022-03-25","current":13.027703,"twenty":-48.601018,"median":-27.551932,"eighty":42.251694,"marketCap":5246386320},{"date":"2022-04-01","current":14.235366,"twenty":-48.601018,"median":-27.316509,"eighty":42.251694,"marketCap":5732724127},{"date":"2022-04-08","current":14.344842,"twenty":-48.601018,"median":-26.794491,"eighty":42.251694,"marketCap":5776811407},{"date":"2022-04-14","current":14.461161,"twenty":-48.601018,"median":-26.508159,"eighty":42.251694,"marketCap":5823654142},{"date":"2022-04-22","current":14.892225,"twenty":-48.601018,"median":-25.384774,"eighty":42.251694,"marketCap":5997247807},{"date":"2022-04-29","current":13.650351,"twenty":-48.601018,"median":-25.016607,"eighty":42.251694,"marketCap":5497132725},{"date":"2022-05-06","current":13.424555,"twenty":-48.601018,"median":11.096922,"eighty":42.251694,"marketCap":5406202710},{"date":"2022-05-13","current":12.804047,"twenty":-48.588669,"median":11.233719,"eighty":42.251694,"marketCap":5568774555},{"date":"2022-05-20","current":14.03947,"twenty":-48.459571,"median":11.423707,"eighty":42.251694,"marketCap":6106088280},{"date":"2022-05-27","current":15.300234,"twenty":-48.421961,"median":11.557862,"eighty":42.251694,"marketCap":6654423825},{"date":"2022-06-03","current":14.451277,"twenty":-48.421961,"median":11.650737,"eighty":42.251694,"marketCap":6285192855},{"date":"2022-06-10","current":13.871579,"twenty":-48.358638,"median":11.793491,"eighty":42.251694,"marketCap":6033068722},{"date":"2022-06-17","current":13.98245,"twenty":-48.187806,"median":11.869839,"eighty":42.251694,"marketCap":6081289185},{"date":"2022-06-24","current":14.856749,"twenty":-48.005095,"median":11.915605,"eighty":42.278935,"marketCap":6461541975},{"date":"2022-07-01","current":14.090154,"twenty":-47.704791,"median":12.042879,"eighty":42.278935,"marketCap":6128131920},{"date":"2022-07-08","current":16.402611,"twenty":-47.438209,"median":12.091073,"eighty":42.278935,"marketCap":7133872995},{"date":"2022-07-15","current":15.572661,"twenty":-47.354824,"median":12.177032,"eighty":42.278935,"marketCap":6772908390},{"date":"2022-07-22","current":15.680364,"twenty":-47.056241,"median":12.207991,"eighty":42.278935,"marketCap":6819751125},{"date":"2022-07-29","current":15.490299,"twenty":-46.767175,"median":12.23207,"eighty":42.278935,"marketCap":6737087475},{"date":"2022-08-05","current":14.296057,"twenty":-46.344161,"median":12.366897,"eighty":42.278935,"marketCap":6217684207},{"date":"2022-08-12","current":16.233243,"twenty":-46.302937,"median":12.703328,"eighty":42.278935,"marketCap":5943802021},{"date":"2022-08-19","current":15.902106,"twenty":-46.302937,"median":12.827162,"eighty":42.278935,"marketCap":5822556176},{"date":"2022-08-26","current":15.160811,"twenty":-46.302937,"median":13.133308,"eighty":42.278935,"marketCap":5551130817},{"date":"2022-09-02","current":14.64529,"twenty":-46.302937,"median":13.239999,"eighty":42.278935,"marketCap":5362373080},{"date":"2022-09-09","current":15.578495,"twenty":-46.302937,"median":13.281221,"eighty":42.278935,"marketCap":5704065918},{"date":"2022-09-16","current":15.792981,"twenty":-46.302937,"median":13.563288,"eighty":42.278935,"marketCap":5782600158},{"date":"2022-09-23","current":14.607661,"twenty":-46.302937,"median":13.650351,"eighty":42.278935,"marketCap":5348595143},{"date":"2022-09-30","current":14.878592,"twenty":-46.302937,"median":13.776558,"eighty":42.278935,"marketCap":5447796289},{"date":"2022-10-07","current":15.616124,"twenty":-46.302937,"median":13.831595,"eighty":42.278935,"marketCap":5717843855},{"date":"2022-10-14","current":16.620824,"twenty":-46.302937,"median":13.871579,"eighty":42.278935,"marketCap":6085714772},{"date":"2022-10-21","current":17.332016,"twenty":-46.302937,"median":13.98245,"eighty":42.278935,"marketCap":6346117782},{"date":"2022-10-28","current":18.152333,"twenty":-46.302937,"median":14.08065,"eighty":42.278935,"marketCap":6646476808},{"date":"2022-11-04","current":17.531451,"twenty":-46.302937,"median":14.156679,"eighty":42.278935,"marketCap":6419140848},{"date":"2022-11-11","current":34.552805,"twenty":-46.302937,"median":14.197857,"eighty":42.278935,"marketCap":7297448740},{"date":"2022-11-18","current":33.893376,"twenty":-46.302937,"median":14.279841,"eighty":42.278935,"marketCap":7158179290},{"date":"2022-11-25","current":35.000961,"twenty":-46.302937,"median":14.343574,"eighty":42.278935,"marketCap":7392097880},{"date":"2022-12-02","current":38.054822,"twenty":-46.302937,"median":14.451277,"eighty":42.278935,"marketCap":8037064167},{"date":"2022-12-09","current":36.447863,"twenty":-46.302937,"median":14.498536,"eighty":42.278935,"marketCap":7697679391},{"date":"2022-12-16","current":36.403048,"twenty":-46.302937,"median":14.543268,"eighty":42.278935,"marketCap":7688214477},{"date":"2022-12-23","current":36.806388,"twenty":-46.302937,"median":14.635007,"eighty":42.278935,"marketCap":7773398704},{"date":"2022-12-30","current":36.428657,"twenty":-46.302937,"median":14.704062,"eighty":42.278935,"marketCap":7693623000},{"date":"2023-01-06","current":35.519541,"twenty":-46.302937,"median":14.81696,"eighty":42.278935,"marketCap":7501620457},{"date":"2023-01-13","current":32.228797,"twenty":-46.302937,"median":14.878592,"eighty":42.278935,"marketCap":6806625339},{"date":"2023-01-20","current":32.945847,"twenty":-46.302937,"median":14.92751,"eighty":42.278935,"marketCap":6958063964},{"date":"2023-01-27","current":32.46568,"twenty":-46.302937,"median":15.157048,"eighty":42.278935,"marketCap":6856654171},{"date":"2023-02-03","current":33.707711,"twenty":-46.302937,"median":15.268557,"eighty":42.278935,"marketCap":7118967503},{"date":"2023-02-10","current":31.319682,"twenty":-46.302937,"median":15.328744,"eighty":42.278935,"marketCap":6614622797},{"date":"2023-02-17","current":32.030329,"twenty":-46.302937,"median":15.540866,"eighty":42.278935,"marketCap":6764709291},{"date":"2023-02-24","current":33.1772,"twenty":-46.302937,"median":15.540866,"eighty":41.822497,"marketCap":6706074343},{"date":"2023-03-03","current":31.054235,"twenty":-46.302937,"median":15.540866,"eighty":40.47977,"marketCap":6276961390},{"date":"2023-03-10","current":27.879832,"twenty":-46.302937,"median":15.540866,"eighty":40.044782,"marketCap":5635322465},{"date":"2023-03-17","current":22.153851,"twenty":-46.302937,"median":15.540866,"eighty":39.771222,"marketCap":4477935794},{"date":"2023-03-24","current":23.106406,"twenty":-46.302937,"median":15.540866,"eighty":39.626718,"marketCap":4670474800},{"date":"2023-03-31","current":25.585203,"twenty":-46.293548,"median":15.556763,"eighty":39.39837,"marketCap":5171511529},{"date":"2023-04-06","current":25.076045,"twenty":-46.293548,"median":15.556763,"eighty":39.156742,"marketCap":5068595876},{"date":"2023-04-14","current":24.452996,"twenty":-46.302937,"median":15.540866,"eighty":38.921373,"marketCap":4942659618},{"date":"2023-04-21","current":22.711139,"twenty":-46.302937,"median":15.540866,"eighty":38.465051,"marketCap":4590579754},{"date":"2023-04-28","current":21.59903,"twenty":-46.302937,"median":15.540866,"eighty":38.197119,"marketCap":4365790303},{"date":"2023-05-05","current":20.681205,"twenty":-46.302937,"median":15.540866,"eighty":37.874762,"marketCap":4180271298},{"date":"2023-05-12","current":24.595079,"twenty":-46.302937,"median":15.540866,"eighty":37.64681,"marketCap":4467351802},{"date":"2023-05-19","current":24.826194,"twenty":-46.302937,"median":15.540866,"eighty":37.510811,"marketCap":4509330555},{"date":"2023-05-26","current":24.706909,"twenty":-46.302937,"median":15.540866,"eighty":37.386396,"marketCap":4487664102},{"date":"2023-06-02","current":24.222314,"twenty":-46.302937,"median":15.540866,"eighty":37.197848,"marketCap":4399644136},{"date":"2023-06-09","current":25.467351,"twenty":-46.302937,"median":15.540866,"eighty":37.021834,"marketCap":4625787741},{"date":"2023-06-16","current":25.467351,"twenty":-46.302937,"median":15.540866,"eighty":36.844061,"marketCap":4625787741},{"date":"2023-06-23","current":26.414176,"twenty":-46.312325,"median":15.53334,"eighty":36.769541,"marketCap":4797765212},{"date":"2023-06-30","current":25.847572,"twenty":-46.321714,"median":15.525814,"eighty":36.745485,"marketCap":4694849560},{"date":"2023-07-07","current":27.293903,"twenty":-46.321714,"median":15.525814,"eighty":36.745485,"marketCap":4957555304},{"date":"2023-07-13","current":27.726311,"twenty":-46.337632,"median":15.490299,"eighty":36.735637,"marketCap":5036096197},{"date":"2023-07-19","current":31.088657,"twenty":-46.350691,"median":15.394112,"eighty":36.742202,"marketCap":5646819344},{"date":"2023-07-27","current":32.616996,"twenty":-46.36488,"median":15.350919,"eighty":36.700937,"marketCap":5924420775},{"date":"2023-08-04","current":31.38687,"twenty":-46.367139,"median":15.327561,"eighty":36.657006,"marketCap":5700985477},{"date":"2023-08-11","current":24.853881,"twenty":-46.367139,"median":15.327561,"eighty":36.657006,"marketCap":5808476346},{"date":"2023-08-18","current":23.978943,"twenty":-46.367139,"median":15.327561,"eighty":36.657006,"marketCap":5603998982},{"date":"2023-08-25","current":23.843469,"twenty":-46.367139,"median":15.327561,"eighty":36.657006,"marketCap":5572337971},{"date":"2023-09-01","current":24.024102,"twenty":-46.368268,"median":15.326379,"eighty":36.658072,"marketCap":5614552652},{"date":"2023-09-08","current":22.093593,"twenty":-46.369398,"median":15.326379,"eighty":36.659137,"marketCap":5163383243},{"date":"2023-09-15","current":22.87257,"twenty":-46.402111,"median":15.326379,"eighty":36.666799,"marketCap":5345434057},{"date":"2023-09-22","current":22.52824,"twenty":-46.532961,"median":15.269935,"eighty":36.697446,"marketCap":5264962320},{"date":"2023-09-28","current":21.704105,"twenty":-46.622347,"median":15.265132,"eighty":36.707918,"marketCap":5072357836},{"date":"2023-10-06","current":21.252524,"twenty":-46.716032,"median":15.217074,"eighty":36.7149,"marketCap":4966821132},{"date":"2023-10-13","current":20.625956,"twenty":-46.750127,"median":15.17192,"eighty":36.7149,"marketCap":4820388955},{"date":"2023-10-20","current":20.208243,"twenty":-46.767175,"median":15.158929,"eighty":36.718391,"marketCap":4722767504},{"date":"2023-11-03","current":19.333305,"twenty":-46.880825,"median":14.989795,"eighty":36.745485,"marketCap":4518290140},{"date":"2023-11-10","current":19.083127,"twenty":-46.909238,"median":14.939111,"eighty":36.697446,"marketCap":4845358674},{"date":"2023-11-17","current":20.560665,"twenty":-46.931968,"median":14.92751,"eighty":36.542616,"marketCap":5220517307},{"date":"2023-11-24","current":21.008088,"twenty":-46.931968,"median":14.92751,"eighty":36.449953,"marketCap":5334121681},{"date":"2023-12-01","current":20.087229,"twenty":-46.931968,"median":14.92751,"eighty":36.356952,"marketCap":5100308027},{"date":"2023-12-08","current":20.888429,"twenty":-46.920603,"median":14.933311,"eighty":36.141801,"marketCap":5303739116},{"date":"2023-12-15","current":20.524247,"twenty":-46.931968,"median":14.92751,"eighty":36.079753,"marketCap":5211270439},{"date":"2023-12-22","current":19.187179,"twenty":-46.931968,"median":14.92751,"eighty":35.721851,"marketCap":4871778296},{"date":"2023-12-29","current":19.327649,"twenty":-46.943333,"median":14.916709,"eighty":35.325033,"marketCap":4907444786},{"date":"2024-01-05","current":19.015493,"twenty":-46.954698,"median":14.905909,"eighty":35.163222,"marketCap":4828185920},{"date":"2024-01-12","current":17.704439,"twenty":-46.954698,"median":14.905909,"eighty":34.692374,"marketCap":4495298683},{"date":"2024-01-19","current":18.172673,"twenty":-46.966063,"median":14.903503,"eighty":34.445855,"marketCap":4614186982},{"date":"2024-01-26","current":17.954164,"twenty":-46.954698,"median":14.905909,"eighty":34.196791,"marketCap":4558705776},{"date":"2024-02-02","current":17.824099,"twenty":-46.954698,"median":14.905909,"eighty":33.895513,"marketCap":4525681248},{"date":"2024-02-09","current":18.333953,"twenty":-46.954698,"median":14.905909,"eighty":33.717272,"marketCap":4655137396},{"date":"2024-02-16","current":18.682527,"twenty":-46.954698,"median":14.905909,"eighty":33.243878,"marketCap":4743643130},{"date":"2024-02-23","current":17.889163,"twenty":-46.954698,"median":14.939111,"eighty":33.170623,"marketCap":5037481056},{"date":"2024-03-01","current":17.929698,"twenty":-46.943333,"median":15.158929,"eighty":33.164046,"marketCap":5048895288},{"date":"2024-03-08","current":18.819435,"twenty":-46.943333,"median":15.269246,"eighty":33.164046,"marketCap":5299439858},{"date":"2024-03-15","current":18.404333,"twenty":-46.943333,"median":15.350919,"eighty":33.164046,"marketCap":5182549791},{"date":"2024-03-22","current":18.147151,"twenty":-46.943333,"median":15.556763,"eighty":33.164046,"marketCap":5110128772},{"date":"2024-03-28","current":18.377261,"twenty":-46.943333,"median":15.649732,"eighty":33.164046,"marketCap":5174926526},{"date":"2024-04-05","current":17.926064,"twenty":-46.954698,"median":15.792981,"eighty":33.170623,"marketCap":5047872106},{"date":"2024-04-12","current":17.741073,"twenty":-46.954698,"median":15.892604,"eighty":33.170623,"marketCap":4995779794},{"date":"2024-04-19","current":17.059766,"twenty":-46.954698,"median":15.951024,"eighty":33.170623,"marketCap":4803927620},{"date":"2024-04-26","current":17.353044,"twenty":-46.943333,"median":16.005059,"eighty":33.164046,"marketCap":4886512993},{"date":"2024-05-03","current":17.966672,"twenty":-46.943333,"median":16.227598,"eighty":33.164046,"marketCap":5059307004},{"date":"2024-05-10","current":17.502061,"twenty":-46.767175,"median":16.356055,"eighty":33.164046,"marketCap":5579692160},{"date":"2024-05-17","current":18.120861,"twenty":-46.767175,"median":16.566262,"eighty":33.164046,"marketCap":5776966860},{"date":"2024-05-24","current":17.533999,"twenty":-46.767175,"median":16.852199,"eighty":33.164046,"marketCap":5589874080},{"date":"2024-05-31","current":17.306441,"twenty":-46.767175,"median":17.172565,"eighty":33.164046,"marketCap":5517327900},{"date":"2024-06-07","current":20.536178,"twenty":-46.767175,"median":17.309821,"eighty":33.164046,"marketCap":6546974560},{"date":"2024-06-14","current":19.809587,"twenty":-46.767175,"median":17.402675,"eighty":33.170623,"marketCap":6315335880},{"date":"2024-06-21","current":20.304627,"twenty":-46.532961,"median":17.450051,"eighty":33.1772,"marketCap":6473155640},{"date":"2024-06-28","current":20.612031,"twenty":-46.331914,"median":17.494077,"eighty":33.184359,"marketCap":6571156620},{"date":"2024-07-05","current":20.763737,"twenty":-45.974566,"median":17.522348,"eighty":33.184359,"marketCap":6619520740},{"date":"2024-07-12","current":21.087109,"twenty":-45.287382,"median":17.583154,"eighty":33.184359,"marketCap":6722612680},{"date":"2024-07-15","current":21.230831,"twenty":-45.146843,"median":17.610792,"eighty":33.184359,"marketCap":6768431320},{"date":"2024-08-02","current":21.977383,"twenty":-43.257065,"median":17.697409,"eighty":33.428092,"marketCap":7006433700},{"date":"2024-08-09","current":20.453728,"twenty":-41.862744,"median":17.753971,"eighty":33.428092,"marketCap":6898899128},{"date":"2024-08-16","current":22.196388,"twenty":-41.08099,"median":17.858016,"eighty":33.428092,"marketCap":7486686348},{"date":"2024-08-23","current":23.150345,"twenty":-40.8644,"median":17.919303,"eighty":33.428092,"marketCap":7808449179},{"date":"2024-08-30","current":23.939049,"twenty":-40.454755,"median":17.960418,"eighty":33.428092,"marketCap":8074473567},{"date":"2024-09-06","current":22.928756,"twenty":-40.062342,"median":18.00728,"eighty":33.428092,"marketCap":7733708994},{"date":"2024-09-13","current":22.737214,"twenty":-39.754377,"median":18.083983,"eighty":33.428092,"marketCap":7669103071},{"date":"2024-09-20","current":22.346618,"twenty":-39.365193,"median":18.151998,"eighty":33.428092,"marketCap":7537357660},{"date":"2024-09-27","current":21.388905,"twenty":-38.756523,"median":18.192317,"eighty":33.428092,"marketCap":7214328046},{"date":"2024-10-04","current":22.695901,"twenty":-37.540812,"median":18.229882,"eighty":33.428092,"marketCap":7655168460},{"date":"2024-10-11","current":19.578642,"twenty":-35.643925,"median":18.269503,"eighty":33.428092,"marketCap":6603738736},{"date":"2024-10-18","current":19.634978,"twenty":-34.449305,"median":18.362536,"eighty":33.428092,"marketCap":6622740478},{"date":"2024-10-25","current":18.515769,"twenty":-33.785204,"median":18.435917,"eighty":33.428092,"marketCap":6245239204},{"date":"2024-10-31","current":19.000258,"twenty":-32.464634,"median":18.485706,"eighty":33.428092,"marketCap":6408654185},{"date":"2024-11-08","current":19.336888,"twenty":-31.257568,"median":18.56807,"eighty":33.455779,"marketCap":7589090550},{"date":"2024-11-15","current":17.492347,"twenty":-28.558242,"median":18.657004,"eighty":33.455779,"marketCap":6865168920},{"date":"2024-11-22","current":14.814682,"twenty":11.103114,"median":18.657004,"eighty":33.455779,"marketCap":5814273900},{"date":"2024-11-29","current":15.625113,"twenty":11.207416,"median":18.657004,"eighty":33.455779,"marketCap":6132341400},{"date":"2024-12-06","current":15.579729,"twenty":11.391373,"median":18.657004,"eighty":33.455779,"marketCap":6114529620},{"date":"2024-12-13","current":15.50517,"twenty":11.541312,"median":18.657004,"eighty":33.455779,"marketCap":6085267410},{"date":"2024-12-20","current":15.339842,"twenty":11.652113,"median":18.657004,"eighty":33.455779,"marketCap":6020381640},{"date":"2024-12-27","current":15.570004,"twenty":11.778699,"median":18.657004,"eighty":33.455779,"marketCap":6110712810},{"date":"2025-01-03","current":15.563521,"twenty":11.834396,"median":18.657004,"eighty":33.455779,"marketCap":6108168270},{"date":"2025-01-10","current":17.427512,"twenty":11.891607,"median":18.669766,"eighty":33.483467,"marketCap":6839723520},{"date":"2025-01-17","current":17.94943,"twenty":12.010873,"median":18.669766,"eighty":33.483467,"marketCap":7044558990},{"date":"2025-01-24","current":18.033715,"twenty":12.07327,"median":18.669766,"eighty":33.483467,"marketCap":7077638010},{"date":"2025-01-31","current":18.289811,"twenty":12.13907,"median":18.669766,"eighty":33.483467,"marketCap":7178147340},{"date":"2025-02-07","current":18.782553,"twenty":12.191859,"median":18.683301,"eighty":33.483467,"marketCap":7371532380},{"date":"2025-02-14","current":18.999749,"twenty":12.221409,"median":18.765769,"eighty":33.483467,"marketCap":7456774470},{"date":"2025-02-21","current":15.928961,"twenty":12.283245,"median":18.781965,"eighty":33.483467,"marketCap":7073908320},{"date":"2025-02-28","current":16.001063,"twenty":12.580528,"median":18.781965,"eighty":33.483467,"marketCap":7105928100},{"date":"2025-03-07","current":16.680484,"twenty":12.783177,"median":18.782553,"eighty":33.511154,"marketCap":7407652950},{"date":"2025-03-14","current":16.932841,"twenty":13.048136,"median":18.782553,"eighty":33.511154,"marketCap":7519722180},{"date":"2025-03-21","current":17.836887,"twenty":13.16718,"median":18.782553,"eighty":33.511154,"marketCap":7921200960},{"date":"2025-03-28","current":17.881257,"twenty":13.275717,"median":18.782553,"eighty":33.511154,"marketCap":7940905440},{"date":"2025-04-04","current":17.171331,"twenty":13.494491,"median":18.782553,"eighty":33.511154,"marketCap":7625633760},{"date":"2025-04-11","current":16.050476,"twenty":13.630199,"median":18.781965,"eighty":33.483467,"marketCap":7127871987},{"date":"2025-04-17","current":16.362028,"twenty":13.693319,"median":18.781965,"eighty":33.483467,"marketCap":7266229294}],"updateTime":1745021018300}}}